The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Rationale The DSM-IV includes the specifier "generalized" to refer to social anxiety disorder (social phobia) patients if the fears include "most social situations". The focus on interventions such as the selective serotonin reuptake inhibitors (SSRIs) for generalized social anxiety disorder arguably runs the risk that inadequate treatment will be provided to patients with the non-generalized or discrete subtypes. There are, however, few data to address whether more generalized and less generalized subgroups of social anxiety disorder differ in response to medication.Objective To compare response of more generalized and less generalized social anxiety disorder to pharmacotherapy.Methods Data from three randomized placebo-controlled double-blind multicenter trials of the SSRI paroxetine in social anxiety disorder were pooled. Response on the Clinical Global Impression Global Improvement item was analyzed using logistic regression, and change in total Liebowitz Social Anxiety Score was analyzed using analysis of variance, with both models incorporating treatment (paroxetine vs placebo), subgroup (more generalized vs less generalized), demographic, and clinical variables.Results The prevalence of more generalized social anxiety disorder was higher in females than in males. However, there was no significant difference in terms of age or clinical characteristics (duration of condition, baseline pulse, mean arterial blood pressure). At treatment endpoint there were significant treatment effects (for paroxetine vs placebo), but no significant subgroup effects (for more generalized vs less generalized).Conclusions Although the current database is limited insofar as few patients with discrete social anxiety disorder would have been included, it is helpful in addressing the value of medication for patients lying on the spectrum from generalized to non-generalized and discrete social anxiety disorder. Paroxetine was effective in both more generalized and in less generalized social anxiety disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SSRIs, on the other hand, may be useful for patients with both more limited or more generalized social anxiety disorder 99 .”
From The clinical characterization of the adult patient with an anxiety or related disorder aimed at personalization of management (2021) · cites this paper as [99]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
(1976) · Medical Entomology and Zoology · Cited by 8,899
Schneier (1992) · doi:10.1001/archpsyc.1992.01820040034004 · Cited by 1,142 · cited 1×
“National and cross-national studies of social anxiety disorder (or social phobia) have documented that this disorder is highly prevalent in many countries (with prevalences ranging, for example, from 2.6 to 13.3% in the United States), that it has a chronic course when untreated, and that it is associated with signifi…”
BackgroundInfluentialPsychometric properties of the Liebowitz Social Anxiety Scale
HEIMBERG, R. G., HORNER, K. J., JUSTER, H. R., SAFREN, S. A., BROWN, E. J., SCHNEIER, F. R., & LIEBOWITZ, M. R. (1999) · Psychological Medicine · doi:10.1017/s0033291798007879 · Cited by 968 · cited 2×
“As part of the post hoc analysis of the data, two definitions of more generalized and less generalized social anxiety disorder were devised using the baseline LSAS, a 24-item scale in which fear/anxiety and avoidance associated with different social situations are each rated on a 4-point scale (absent, mild, moderate,…”
MethodMcDougle, C. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040046006 · Cited by 570
Functional impairment in social phobia.
Schneier, F. R., Heckelman, L., Garfinkel, R. S., Campeas, R. B., Fallon, B. A., Gitow, A., Street, L. L., Bene, D. D., & Liebowitz, M. R. (1994) · PubMed · Cited by 534
Phenelzine vs Atenolol in Social Phobia: A Placebo-Controlled Comparison
Liebowitz, M. R., Schneier, F., Campeas, R., Hollander, E., Hatterer, J., Fyer, A., Gorman, J., Papp, L., Davies, S., Gully, R., et al. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.49.4.290 · Cited by 444
Social Phobia Subtypes in the National Comorbidity Survey
Kessler, R. C., Stein, M. B., & Berglund, P. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.5.613 · Cited by 398
Self-citationSocial phobia: A comparison of specific and generalized subtypes and avoidant personality disorder.
Turner, S. M., Beidel, D. C., & Townsley, R. M. (1992) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.101.2.326 · Cited by 282 · cited 1×
“Further understanding of the heterogeneity of social anxiety disorder (Holt et al. 1992; Turner et al. 1992 ) may be useful for predicting response to pharmacotherapy.”
BackgroundGeneralized Social Phobia: Reliability and Validity
Mannuzza, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950150062011 · Cited by 278
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.3.408 · Cited by 270
Self-citationvan Vliet, I. M., den Boer, J. A., & Westenberg, H. G. M. (1994) · Psychopharmacology · doi:10.1007/bf02244762 · Cited by 269
Social Phobia Symptoms, Subtypes, and Severity: Findings From a Community Survey
Stein, M. B., Torgrud, L. J., & Walker, J. R. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.11.1046 · Cited by 266 · cited 2×
“Recent reports indicate the existence of a continuum of severity from many to few social fears, in both treatment-seeking (Eng et al. 2000) and community (Furmark et al. 2000; Stein et al. 2000 ) samples.”
BackgroundSelf-citationStein, M. B., Fyer, A. J., Davidson, J. R. T., Pollack, M. H., & Wiita, B. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.756 · Cited by 262
Self-citationHEIMBERG, R. G., HOPE, D. A., DODGE, C. S., & BECKER, R. E. (1990) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199003000-00004 · Cited by 257
Sertraline for social phobia: a double-blind, placebo-controlled crossover study
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1368 · Cited by 238
Avoidant personality disorder and the generalized subtype of social phobia.
Holt, C. S., Heimberg, R. G., & Hope, D. A. (1992) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.101.2.318 · Cited by 236 · cited 1×
“Further understanding of the heterogeneity of social anxiety disorder ( Holt et al. 1992; Turner et al. 1992) may be useful for predicting response to pharmacotherapy.”
BackgroundThe Boundary of Social Phobia: Exploring the Threshold
Davidson, J. R. T. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950120047008 · Cited by 214
The issue of subtypes in the diagnosis of social phobia
Heimberg, R. G., Holt, C. S., Schneier, F. R., Spitzer, R. L., & Liebowitz, M. R. (1993) · Journal of Anxiety Disorders · doi:10.1016/0887-6185(93)90006-7 · Cited by 201 · cited 1×
“The DSM-III-R and DSM-IV distinction between generalized and non-generalized social anxiety disorder has arguably received some empirical support, but has also been criticized on several grounds including inadequate operational definition and lack of validity (Heckelman and Schneier 1995; Heimberg et al. 1993 ).”
BackgroundAn examination of syndromal validity and diagnostic subtypes in social phobia and panic disorder.
Gelernter, C. S., Stein, M. B., Tancer, M. E., & Uhde, T. W. (1992) · PubMed · Cited by 128
Self-citationSocial phobia subtypes in the general population revealed by cluster analysis
FURMARK, T., TILLFORS, M., STATTIN, H., EKSELIUS, L., & FREDRIKSON, M. (2000) · Psychological Medicine · doi:10.1017/s0033291799002615 · Cited by 128
Fluoxetine for the Treatment of Social Phobia
BLACK, B., UHDE, T. W., & TANCER, M. E. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199208000-00022 · Cited by 106 · cited 1×
“Although a distinction between more generalized and less generalized social anxiety disorder has not been a focus of pharmacotherapy research, several previous studies have shown high rates of response of social anxiety disorder to treatment with SSRIs ( Black et al. 1992; Bouwer and Stein 1998; Katzelnick et al. 1995…”
ResultThe cross-national epidemiology of social phobia: a preliminary report
Weissman, M. M., Bland, R. C., Canino, G. J., Greenwald, S., Lee, C. K., Newman, S. C., Rubio-Stipec, M., & Wickramaratne, P. J. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00003 · Cited by 100
Subtypes of social phobia and comorbidity with depression and other anxiety disorders.
Stein, M., & Chavira, D. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00092-5 · Cited by 95 · cited 1×
“tics and family history (Kessler et al. 1998), social anxiety disorder characterized exclusively by speaking fears is less persistent, less impairing, and less highly comorbid with other psychiatric disorders (Gelernter et al. 1992; Kessler et al. 1998; Stein and Chavira 1998 ).”
BackgroundSelf-citationBouwer, C., & Stein, D. J. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00182-1 · Cited by 86
Self-citationSCHNEIER, F. R., CHIN, S. J., HOLLANDER, E., & LIEBOWITZ, M. R. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199202000-00018 · Cited by 68
An empirical approach to subtype identification in individuals with social phobia
ENG, W., HEIMBERG, R. G., COLES, M. E., SCHNEIER, F. R., & LIEBOWITZ, M. R. (2000) · Psychological Medicine · doi:10.1017/s0033291799002895 · Cited by 55
Implications of the severity of social phobia
Montgomery, S. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00093-7 · Cited by 42 · cited 1×
“In addition, the analysis here necessarily overlaps in part with a previous analysis focusing on paroxetine in more severe versus less severe social anxiety disorder ( Montgomery 1998 ).”
REICH, J., GOLDENBERG, I., GOISMAN, R., VASILE, R., & KELLER, M. (1994) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199405000-00008 · Cited by 34 · cited 1×
“On the other hand, clinical comparisons of generalized and non-generalized social anxiety disorder patients have suggested that these subgroups represent a continuum of overlapping conditions (Weinshenker et al. 1996/1997), and have found that this differentiation does not predict clinical course ( Reich et al. 1994 ).”
BackgroundWeinshenker, N. J., Goldenberg, I. M., Rogers, M. P., Goisman, R. M., Warshaw, M. G., Fierman, E. J., Vasile, R. G., & Keller, M. B. (1996) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1996)4:5<209::aid-da1>3.0.co;2-8 · Cited by 13 · cited 1×
“On the other hand, clinical comparisons of generalized and non-generalized social anxiety disorder patients have suggested that these subgroups represent a continuum of overlapping conditions ( Weinshenker et al. 1996 /1997), and have found that this differentiation does not predict clinical course (Reich et al. 1994).”
BackgroundWeinshenker, N. J., Goldenberg, I. M., Rogers, M. P., Goisman, R. M., Warshaw, M. G., Fierman, E. J., Vasile, R. G., & Keller, M. B. (1996) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1996)4:5<237::aid-da5>3.0.co;2-a · Cited by 12
Cited by
Blomstrom-Lundqvist (2003) · doi:10.1161/01.cir.0000091380.04100.84 · Cited by 955
Blomström-Lundqvist, C., Scheinman, M. M., Aliot, E. M., Alpert, J. S., Calkins, H., Camm, A. J., Campbell, W. B., Haines, D. E., Kuck, K. H., Lerman, B. B., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.013 · Cited by 689
BlomstromLundqvist, C. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.08.002 · Cited by 263
Social Anxiety Disorder: (532272011-001)
(2008) · PsycEXTRA Dataset · doi:10.1037/e532272011-001 · Cited by 258
Self-citationPigott, T. A. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00040-6 · Cited by 205
Metadata
- Authors
- Stein, D., Stein, M., Goodwin, W., Kumar, R., & Hunter, B.
- Affiliations
- Stellenbosch University (ZA)
- University of California San Diego (US)
- GlaxoSmithKline (United Kingdom) (GB)
- Venue
- Psychopharmacology
- Published
- 2001-11-01
- Volume
- 158
- Issue
- 3
- Pages
- 267-272
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2065666574
- Cited by
- 39
- References
- 31
- Citations by year
- 2022: 1 · 2021: 1 · 2018: 1 · 2016: 2 · 2013: 1
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- paroxetine, social anxiety disorder, generalized social anxiety, selective serotonin reuptake inhibitors, pharmacotherapy response, Liebowitz Social Anxiety Scale, Clinical Global Impression Scale
- MeSH terms
- Adult, Analysis of Variance, Anxiety Disorders, Double-Blind Method, Female, Humans, Male, Middle Aged, Confidence Intervals, Logistic Models, Odds Ratio, Selective Serotonin Reuptake Inhibitors, Paroxetine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.